A Pilot Study of Immune Activation and Rifampin Absorption in HIV-Infected Patients without Tuberculosis Infection: A Short Report

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static-preview.hindawi.com/articles/trt/volume-2017/2140974/figures/2140974.fig.002a.svgz" name="2140974.fig.002a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Subject 103</td></tr><tr class="fig-image" id="b"><td><object data="https://static-preview.hindawi.com/articles/trt/volume-2017/2140974/figures/2140974.fig.002b.svgz" name="2140974.fig.002b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Subject 104</td></tr><tr class="fig-image" id="c"><td><object data="https://static-preview.hindawi.com/articles/trt/volume-2017/2140974/figures/2140974.fig.002c.svgz" name="2140974.fig.002c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>Subject 105</td></tr><tr class="fig-image" id="d"><td><object data="https://static-preview.hindawi.com/articles/trt/volume-2017/2140974/figures/2140974.fig.002d.svgz" name="2140974.fig.002d" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(d) </b>Subject 106</td></tr></table>

<div>Flow cytometry results for CD8+ T cells. Panel 1: gating of lymphocytes; panel 2: live/dead staining; panel 3: CD3+ CD8+; panel 4: CD8+ HLA-DR+; panel 5: CD8+ CD38+; panel 6: CD8+ CD57+.</div>

Tuberculosis Research and Treatment

fig2

Figure 2

Figure 2: A Pilot Study of Immune Activation and Rifampin Absorption in HIV-Infected Patients without Tuberculosis Infection: A Short Report 